This week's highest-impact publications across 29 specialties, curated by AI
Last updated: 11 de mai. de 2026
Published: 2026-12-01
Annals of medicine
MediLens Indexed: 2026-05-12
This study investigates the variation in ischemic stroke admissions among patients with atrial fibrillation (AF) based on the day of the week. Analyzing data from the nationwide FinACAF study, which included 13,781 patients with a mean age of 79.2 years, the results show significant differences i...
Read on PubMedPublished: 2026-05-11
Hypertension (Dallas, Tex. : 1979)
MediLens Indexed: 2026-05-12
The WISDOM-HMOD study evaluated the relationship between nighttime blood pressure measured by a wrist-type monitor and left ventricular hypertrophy in 1218 patients with hypertension or heart failure. Results showed an average nighttime systolic/diastolic BP of 110.5±13.0/63.5±8.8 mm Hg, with 70....
Read on PubMedPublished: 2026-05-11
Circulation. Heart failure
MediLens Indexed: 2026-05-12
This review addresses the significant advancements in cardiac gene therapy for cardiomyopathy, highlighting the transition of adeno-associated virus-mediated gene replacement into early-phase clinical trials. It notes improvements in biomarkers like NT-proBNP and discusses the challenges in deliv...
Read on PubMedPublished: 2026-05-11
Medical science monitor : international medical journal of experimental and clinical research
MediLens Indexed: 2026-05-12
This study evaluated the impact of a structured, multidisciplinary case management model on cardiac function and glycemic control in elderly patients with coronary heart disease and diabetes undergoing off-pump CABG. A total of 168 patients were randomized to receive either routine care or an enh...
Read on PubMedPublished: 2026-05-11
Cardiology in review
MediLens Indexed: 2026-05-12
This study highlights the critical role of sodium-glucose cotransporter 2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists in reducing cardiovascular and kidney disease risks in patients with type 2 diabetes. Empagliflozin showed significant benefits in reducing cardiovascular m...
Read on PubMedJoin physicians worldwide who start their morning with AI-curated literature reviews, delivered to your inbox at 7 AM.
Start 14-Day Free Trial